Skip to main content Skip to navigation
Menu
800-789-7366

Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Celeste P. Durnwald, MD

Celeste P. Durnwald, MD Physician

Director, Penn Perinatal Diabetes Program Medical Director, High Risk OB Clinic, Dickens Center for Women's Health Associate Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Durnwald is employed by Penn Medicine.

Request a Callback
No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.
X

About Dr. Celeste P. Durnwald

Patients seen by this provider for their prenatal care will deliver at the Hospital of the University of Pennsylvania. Dr. Durnwald specializes in diabetes in pregnancy (type 1, type 2, and gestational diabetes). She sees patients for consultative care and ongoing co-management of diabetes, prenatal care and preconceptional counseling.

Clinical Specialties

Specialty:

  • Maternal Fetal Medicine

Programs & Centers:

Board Certification:

  • Obstetrics and Gynecology - Maternal and Fetal Medicine, 2007
  • Obstetrics and Gynecology, 2006

Clinical Expertise:

  • Abruptio Placentae
  • Fetal Abnormalities
  • Gestational Diabetes
  • HELLP Syndrome
  • High-Risk Pregnancy
  • Obstetrical Sonography
  • Perinatal Depression
  • Peripartum Cardiomyopathy
  • Placenta Disorders
  • Placenta Previa
  • Preeclampsia
  • Pregnancy Complications
  • Preterm Labor
  • Renal Disease and Pregnancy

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Northeastern Ohio University - College of Medicine
Residency: Summa Health System Hospital
Fellowship: MetroHealth Medical Center

Memberships

American College of Obstetricians and Gynecologists, National American Diabetes Association, National Society for Maternal Fetal Medicine, National

Hospital Affiliation

Dr. Durnwald is employed by Penn Medicine.

Hospital Privileges:

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Areas of research interest include: 1) diabetes in pregnancy, 2) obesity,
3) maternal metabolism

Selected Publications:

Maeve Hopkins, Lorraine Dugoff, Celeste Durnwald, Laura Havrilesky, Sarah Dotters-Katz: Cell-free DNA for Down syndrome screening in morbidly obese women: Is it a cost-effective strategy? Poster Presentation, Society for Maternal Fetal Medicine, Las Vegas, NV : 2019.

Sindhu K. Srinivas, Celeste Durnwald, Laura Line, Melissa Patti, Melissa Bucher, Shayna Cunningham, Valerie Riis: Safe Start”: A community health worker program that improves perinatal outcomes in high risk women American Journal of Obstetrics & Gynecology, Vol. 220, Issue 1, S208 Published in issue: January 2019 Poster presentation, Society for Maternal Fetal Medicine, Las Vegas, NV : 2019.

Maeve Hopkins, Nathanael Koelper, Whitney Burns, Celeste Durnwald, Mary Sammel, Lorraine Dugoff: Cell-free DNA fetal fraction and risk for gestational diabetes Poster presentation, Society for Maternal Fetal Medicine, Las Vegas, NV : 2019.

Teefey CP, Durnwald CP, Srinivas SK, Levine LD.: Adverse Maternal Outcomes Differ between Obese and Nonobese Women with Severe Preeclampsia. Am J Perinatol 36(1):74-78. : 2019.

Reforma L, Paidas Teefey C, Durnwald C, Srinivas S, Sammel M, Wang E: Late third trimester ultrasound improves accuracy of predicted birthweight in women with class III obesity. Poster, ACOG Annual Clinical and Scientific Meeting. Austin, TX, : 2018.

Durnwald C, Downes K, Leite R, Elovitz MA, Parry S, Maternal Child Health Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA: Predicting persistent impaired glucose tolerance in GDM women: the role of hsCRP and adiponectin. Diabetes/Metabolism Research and Reviews 34(2) : 2018.

Teefey CP, Reforma L, Levine LD, Srinivas SK, Durnwald CP: Risk factors associated with cesarean delivery after induction of labor in women with class III Obesity. Poster presentation, Society for Maternal Fetal Medicine, annual meeting, Dallas, TX, : 2018.

Burns WR, Koelper N, Sammel MD, Durnwald CP: Validation of a breastfeeding history questionnaire for the prediction of in-hospital formula supplementation in multiparous women. Poster presentation, Society for Maternal Fetal Medicine, annual meeting, Dallas, TX, : 2018.

Durnwald CP: Fibroblast growth factor 21 and metabolic dysfunction in women with a prior glucose intolerant pregnancy. Poster presentation, Society for Maternal Fetal Medicine, annual meeting, Dallas, TX, : 2018.

Durnwald C: Gestational Diabetes: Pathophysiology, Diagnosis and Complications Diabetes and Nutrition, 1st edition, The Academy of Nutrition and Dietetics guide to Pregnancy, : 2017 in press.

Academic Contact Info

Hospital of the University of Pennsylvania
Obstetrics and Gynecology
Division of Maternal Fetal Medicine
3400 Spruce Street, 2000 Courtyard
Philadelphia, PA 19104
Patient appointments: 800-789-7366 (PENN)